The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate-or low-risk patients with advanced-stage follicular lymphoma …
C Buske, E Hoster, M Dreyling, J Hasford, M Unterhalt… - Blood, 2006 - ashpublications.org
The Follicular Lymphoma International Prognostic Index (FLIPI) was developed to predict
prognosis of patients with follicular lymphoma (FL). However, it was based on different …
prognosis of patients with follicular lymphoma (FL). However, it was based on different …
[HTML][HTML] Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort …
Background Because follicular lymphoma (FL) patients have heterogeneous outcomes, the
FL international prognostic index (FLIPI) was developed to risk-stratify patients and to predict …
FL international prognostic index (FLIPI) was developed to risk-stratify patients and to predict …
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early …
F Mir, F Mattiello, A Grigg, M Herold… - American journal of …, 2020 - Wiley Online Library
Patients with advanced‐stage follicular lymphoma (FL) who progress early after receiving
first‐line therapy have poor overall survival (OS). Currently applied clinical prognostic …
first‐line therapy have poor overall survival (OS). Currently applied clinical prognostic …
[HTML][HTML] Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
S Montoto, A Lopez-Guillermo, A Altes, G Perea… - Annals of oncology, 2004 - Elsevier
Background Different prognostic scores have been proposed to predict the outcome of
follicular lymphoma (FL) patients at diagnosis. A new prognostic index specifically …
follicular lymphoma (FL) patients at diagnosis. A new prognostic index specifically …
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …
disease course; however, survival based on lines of treatment remains poorly described in …
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
In follicular lymphoma (FL), no prognostic index has been built based solely on a cohort of
patients treated with initial immunochemotherapy. There is currently a need to define …
patients treated with initial immunochemotherapy. There is currently a need to define …
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome …
W Hiddemann, M Kneba, M Dreyling, N Schmitz… - Blood, 2005 - ashpublications.org
Phase 2 studies suggest that the monoclonal antibody rituximab may improve the prognosis
of patients with follicular lymphoma (FL) when it is added to chemotherapy. In the current …
of patients with follicular lymphoma (FL) when it is added to chemotherapy. In the current …
Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis …
C Casulo, M Byrtek, KL Dawson, X Zhou… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Twenty percent of patients with follicular lymphoma (FL) experience progression of
disease (POD) within 2 years of initial chemoimmunotherapy. We analyzed data from the …
disease (POD) within 2 years of initial chemoimmunotherapy. We analyzed data from the …
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic …
M Federico, M Bellei, L Marcheselli… - Journal of Clinical …, 2009 - ascopubs.org
Purpose The aim of the F2 study was to verify whether a prospective collection of data would
enable the development of a more accurate prognostic index for follicular lymphoma (FL) by …
enable the development of a more accurate prognostic index for follicular lymphoma (FL) by …
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival—a study from the groupe d' …
E Bachy, P Brice, R Delarue, N Brousse… - Journal of clinical …, 2010 - ascopubs.org
Purpose First-line treatment for patients with newly diagnosed follicular lymphoma (FL) still
remains debated, even in the rituximab-based combination therapy era. Few studies have …
remains debated, even in the rituximab-based combination therapy era. Few studies have …